These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 261517)

  • 1. Low urinary kallikrein excretion and elevated blood pressure normalized by orally kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Krück F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():263s-265s. PubMed ID: 261517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Stumpe KO; Overlack A; Ressel C; Krück F
    Agents Actions; 1980 Sep; 10(4):349-52. PubMed ID: 6905641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Kolloch R; Zywzok W; Krück F
    Klin Wochenschr; 1980 Jan; 58(1):37-42. PubMed ID: 6900133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Results of double blind study.
    Overlack A; Stumpe KO; Kolloch R; Ressel C; Krueck F
    Hypertension; 1981; 3(3 Pt 2):I18-21. PubMed ID: 7021412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB; Lilley JJ; Frigon RP; Stone RA
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral administration of extracted kallikrein to patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Ferri C; Luparini RL; Germanò G; Giarrizzo C; Santucci A; Balsano F
    Clin Ter; 1991 Oct 15-31; 139(1-2):3-8. PubMed ID: 1837764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of oral kallikrein in lowering systemic blood pressure in primary hypertension.
    Bönner G; Toussaint C; Claus M; Fritschka E; Philipp T; Vetter H; Feltkamp H
    Agents Actions Suppl; 1992; 38 ( Pt 3)():294-303. PubMed ID: 1462864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
    Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
    Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB; Chud JM; Braunstein H
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy and tolerance of orally administered kallikrein in patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Torregrossa G; Leonetti Luparini R; Germanò G; Giarrizzo C; Ferri C; Santucci A
    Ann Ital Med Int; 1991; 6(4):369-74. PubMed ID: 1804283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary prostaglandins and kallikrein in essential hypertension.
    Weber PC; Scherer B; Held E; Siess W; Stoffel H
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():259s-261s. PubMed ID: 396075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients.
    Bellini C; Ferri C; Piccoli A; Carlomagno A; Di Francesco L; Bonavita MS; Santucci A; Balsano F
    Nephron; 1993; 65(1):28-35. PubMed ID: 8413787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril.
    Madeddu P; Oppes M; Rubattu S; Bandiera F; Dessi'-Fulgheri P; Glorioso N; Soro A; Chiara-Troffa M; Rappelli A
    Agents Actions Suppl; 1987; 22():321-8. PubMed ID: 3324715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure sensitivity to salt in rats with low urinary kallikrein excretion.
    Madeddu P; Varoni MV; Demontis MP; Pinna-Parpaglia P; Glorioso N; Anania V
    Immunopharmacology; 1996 Jun; 33(1-3):301-4. PubMed ID: 8856169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sodium and potassium loading on urinary kallikrein-like activity in young patients with borderline hypertension.
    Ando K; Ito Y; Noda H; Fujita T
    Jpn Circ J; 1985 Nov; 49(11):1151-8. PubMed ID: 3854057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.